Endeavor Biomedicines

📍 San Diego, United States👥 30 employees💰 Last funded Feb 2022
Biotechnology🌐 endeavorbiomedicines.com
Website LinkedIn
Endeavor BioMedicines is a clinical stage company targeting the drivers of fibrosis and oncology. We combine best-in-class therapeutics with an evolving understanding of terminal diseases to develop medicines with the potential to reverse severe health conditions. Our lead program, ENV-101, is a Hedgehog signaling inhibitor with demonstrated clinical activity that we are investigating in IPF. At Endeavor, we are an innovative and focused team that has come together to live up to our name and bold mission: to help patients feel better and live longer.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Endeavor Biomedicines?
Endeavor Biomedicines has 2 investors on record on gritt.io.
When did Endeavor Biomedicines last raise funding?
The most recent investment in Endeavor Biomedicines recorded on gritt.io was in February 2022.
What industry is Endeavor Biomedicines in?
Endeavor Biomedicines operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Endeavor Biomedicines based?
Endeavor Biomedicines is headquartered in San Diego, United States.